SEC Form 4 · accession 0001626533-18-000006
Cell MedX Corp. · CMXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Jeffs
10% Owner
Period of report
Dec 27, 2018
Accepted (ET)
Dec 31, 2018 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001493712
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $0.05 | Dec 27, 2018 | A | 5,000,000 | A | — | Dec 27, 2021 | Common Stock | 5,000,000 | 5,000,000 | D |
| Warrant | $0.05 | Dec 27, 2018 | A | 2,482,960 | A | Dec 27, 2018 | Dec 27, 2021 | Common Stock | 2,482,960 | 2,482,960 | D |
Explanation of responses
- F1The Warrants vest at a rate of 20 warrants for every USD$1 drawn on the Credit Line, dated for reference December 27, 2018. Of the 5,000,000 warrants, 2,000,000 warrants vested on the grant date of the Warrants on account of USD$100,000 advance drawn onto Credit Line and advanced on December 20, 2018.